Vardenafil |
Levitra |
Vardenafil Systematic (IUPAC) name 4-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]- 9-methyl-7-propyl- 3,5,6,8-tetrazabicyclo[4.3.0] nona-3,7,9-trien-2-one Identifiers CAS number 224785-90-4 ATC code G04BE09 PubChem 110634 DrugBank APRD00699 Chemical data Formula C23H32N6O4S Mol. weight 488.604 g/mol Pharmacokinetic data Bioavailability 15% Protein binding 95% Metabolism Hepatic (CYP3A4) Half life 4–5 hours Excretion Biliary Therapeutic consid ...
Wikipedia - [full article]
Vardenafil Clinical Trials
- Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-Sparing Prostatectomy for Improving ED
ClinicalTrials.gov Identifier: NCT00492635 - Active, not recruiting
Sexual Dysfunction; Male Erectile Dysfunction
- Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II
ClinicalTrials.gov Identifier: NCT00377793 - Active, not recruiting
Sexual Dysfunction; Male Erectile Dysfunction
- A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
ClinicalTrials.gov Identifier: NCT00379756 - Active, not recruiting
Erectile Dysfunction
- A Study To Assess If 10 mg Vardenafil (BAY 38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function
ClinicalTrials.gov Identifier: NCT00478881 - Recruiting
Overactive Bladder; Detrusor Overactivity
- Vardenafil In Benign Prostate Hypertrophy
ClinicalTrials.gov Identifier: NCT00461123 - Recruiting
Benign Prostate Hyperplasia (BPH)
- Vardenafil Treatment of Erectile Dysfunction in Depressive and Non-Depressive Men (VALOR)
ClinicalTrials.gov Identifier: NCT00470873 - Recruiting
Male Erectile Dysfunction; Impotence
- Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS
ClinicalTrials.gov Identifier: NCT00517179 - Completed
Prostatic Hyperplasia; Impotence

Not Signed In -


